Ad is loading...
ICCC
Price
$3.61
Change
+$0.01 (+0.28%)
Updated
Nov 15 closing price
NKTX
Price
$2.53
Change
-$0.17 (-6.30%)
Updated
Nov 15 closing price
123 days until earnings call
Ad is loading...

ICCC vs NKTX

Header iconICCC vs NKTX Comparison
Open Charts ICCC vs NKTXBanner chart's image
ImmuCell
Price$3.61
Change+$0.01 (+0.28%)
Volume$2.96K
CapitalizationN/A
Nkarta
Price$2.53
Change-$0.17 (-6.30%)
Volume$1.26M
CapitalizationN/A
ICCC vs NKTX Comparison Chart
Loading...
ICCC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NKTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
ICCC vs. NKTX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ICCC is a Sell and NKTX is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (ICCC: $3.61 vs. NKTX: $2.53)
Brand notoriety: ICCC and NKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ICCC: 13% vs. NKTX: 164%
Market capitalization -- ICCC: $28.28M vs. NKTX: $178.54M
ICCC [@Biotechnology] is valued at $28.28M. NKTX’s [@Biotechnology] market capitalization is $178.54M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ICCC’s FA Score shows that 0 FA rating(s) are green whileNKTX’s FA Score has 1 green FA rating(s).

  • ICCC’s FA Score: 0 green, 5 red.
  • NKTX’s FA Score: 1 green, 4 red.
According to our system of comparison, NKTX is a better buy in the long-term than ICCC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ICCC’s TA Score shows that 4 TA indicator(s) are bullish while NKTX’s TA Score has 4 bullish TA indicator(s).

  • ICCC’s TA Score: 4 bullish, 2 bearish.
  • NKTX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ICCC is a better buy in the short-term than NKTX.

Price Growth

ICCC (@Biotechnology) experienced а +1.98% price change this week, while NKTX (@Biotechnology) price change was -20.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

ICCC is expected to report earnings on Nov 13, 2024.

NKTX is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NKTX($179M) has a higher market cap than ICCC($28.3M). ICCC YTD gains are higher at: -29.077 vs. NKTX (-61.667). ICCC has higher annual earnings (EBITDA): -746.14K vs. NKTX (-115.21M). NKTX has more cash in the bank: 325M vs. ICCC (1.32M). ICCC has less debt than NKTX: ICCC (15.8M) vs NKTX (85.6M). ICCC has higher revenues than NKTX: ICCC (23.2M) vs NKTX (0).
ICCCNKTXICCC / NKTX
Capitalization28.3M179M16%
EBITDA-746.14K-115.21M1%
Gain YTD-29.077-61.66747%
P/E RatioN/AN/A-
Revenue23.2M0-
Total Cash1.32M325M0%
Total Debt15.8M85.6M18%
FUNDAMENTALS RATINGS
ICCC: Fundamental Ratings
ICCC
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ICCCNKTX
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
73%
Momentum
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
87%
MACD
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 12 days ago
85%
Declines
ODDS (%)
Bearish Trend 17 days ago
76%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
ICCC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
NKTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HWNIX12.950.03
+0.23%
Hotchkis & Wiley International Value I
MRVSX34.16-0.22
-0.64%
Victory Integrity Small-Cap Value R
MSVZX10.02-0.08
-0.79%
MassMutual Small Company Val I
FCVTX19.45-0.18
-0.92%
Fidelity Advisor Small Cap Value M
HESAX44.77-0.65
-1.43%
Horizon Defensive Core Advisor

ICCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICCC has been loosely correlated with NKTX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ICCC jumps, then NKTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICCC
1D Price
Change %
ICCC100%
+0.28%
NKTX - ICCC
43%
Loosely correlated
-6.30%
BOLT - ICCC
30%
Poorly correlated
-9.14%
IMMP - ICCC
23%
Poorly correlated
-1.91%
MYNDF - ICCC
23%
Poorly correlated
N/A
IOBT - ICCC
22%
Poorly correlated
-7.87%
More

NKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTX has been loosely correlated with FATE. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTX jumps, then FATE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTX
1D Price
Change %
NKTX100%
-6.30%
FATE - NKTX
51%
Loosely correlated
-2.88%
PGEN - NKTX
51%
Loosely correlated
-7.11%
ALLO - NKTX
47%
Loosely correlated
-7.72%
BCRX - NKTX
46%
Loosely correlated
-5.64%
CRBU - NKTX
45%
Loosely correlated
-4.78%
More